Consensus Statement by the American Association of Clinical Endocrinologists/American College of Endocrinology insulin pump management task force.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Endocrine Practice

• Publication date

  2014-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.4158/EP14145.PSPMID 24816754
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Feasibility of Adjacent Insulin Infusion and Continuous Glucose Monitoring via the Medtronic Combo-Set

  2013cited by this paper
• Threshold-based insulin-pump interruption for reduction of hypoglycemia.

  2013cited by this paper
• Standards of Medical Care in Diabetes—2014

  2013cited by this paper
• The effect of long-term use of U-500 insulin via continuous subcutaneous infusion on durability of glycemic control and weight in obese, insulin-resistant patients with type 2 diabetes.

  2013cited by this paper
• Insulin Pump for Type 2 Diabetes

  2013influential reference
• Prediction of the Risk to Develop Diabetes-Related Late Complications by Means of the Glucose Pentagon Model: Analysis of Data from the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study

  2012cited by this paper
• Clinical Use of U-500 Regular Insulin: Review and Meta-Analysis

  2012cited by this paper
• Acceleration of insulin pharmacodynamic profile by a novel insulin infusion site warming device

  2012cited by this paper
• Microneedle delivery: clinical studies and emerging medical applications.

  2012cited by this paper
• Guidelines for Application of Continuous Subcutaneous Insulin Infusion (Insulin Pump) Therapy in the Perioperative Period

  2012cited by this paper
• Cost-effectiveness of sensor-augmented pump therapy in adults with type 1 diabetes in the United States.

  2012influential reference
• PMD19 Multiple Daily Injection Therapy (MDI) Versus Durable Insulin Pump Therapy in Type II Diabetics: A Breakeven Analysis

  2012influential reference
• The T1D Exchange clinic registry.

  2012cited by this paper
• Insulin pumps

  2012cited by this paper
• A 16-Week Open-Label, Multicenter Pilot Study Assessing Insulin Pump Therapy in Patients with Type 2 Diabetes Suboptimally Controlled with Multiple Daily Injections

  2011influential reference
• Use of recombinant human hyaluronidase to accelerate rapid insulin analogue absorption: experience with subcutaneous injection and continuous infusion.

  2011cited by this paper
• External insulin pump treatment in the day-to-day management of diabetes: benefits and future prospectives.

  2011cited by this paper
• Use of U-500 Regular Insulin via Continuous Subcutaneous Insulin Infusion: Clinical Practice Experience

  2011cited by this paper
• Effect of educational components and strategies associated with insulin pump therapy: a systematic review.

  2011cited by this paper
• National Standards for Diabetes Self-Management Education

  2010cited by this paper
• Using Insulin Pump Therapy in Poorly Controlled Type 2 Diabetes

  2010influential reference
• Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes.

  2010cited by this paper
• [Cost-effectiveness of continuous subcutaneous insulin infusion therapy for type 1 diabetes].

  2010influential reference
• Statement by the American Association of Clinical Endocrinologists Consensus Panel on insulin pump management.

  2010cited by this paper
• Insulin Pump Use in Type 2 Diabetes

  2010influential reference
• A prospective trial of U500 insulin delivered by Omnipod in patients with type 2 diabetes mellitus and severe insulin resistance.

  2010cited by this paper
• Insulin Pump Therapy in Patients with Type 2 Diabetes Safely Improved Glycemic Control Using a Simple Insulin Dosing Regimen

  2010cited by this paper
• Resource utilization with insulin pump therapy for type 2 diabetes mellitus.

  2010influential reference
• Pilot Study for Assessment of Optimal Frequency for Changing Catheters in Insulin Pump Therapy—Trouble Starts on Day 3

  2010cited by this paper
• Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus.

  2010cited by this paper
• Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation.

  2010influential reference
• American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control.

  2009cited by this paper
• Health economic comparison between continuous subcutaneous insulin infusion and multiple daily injections of insulin for the treatment of adult type 1 diabetes in Canada.

  2009influential reference
• The diagnosis and management of monogenic diabetes in children and adolescents

  2009cited by this paper
• A cost-effectiveness analysis of continuous subcutaneous insulin injection versus multiple daily injections in type 1 diabetes patients: a third-party US payer perspective.

  2009influential reference
• American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients - 2009 update.

  2009cited by this paper
• Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes

  2009cited by this paper
• Clinical review: Hypoglycemia with intensive insulin therapy: a systematic review and meta-analyses of randomized trials of continuous subcutaneous insulin infusion versus multiple daily injections.

  2009cited by this paper
• A 2‐yr national population study of pediatric ketoacidosis in Sweden: predisposing conditions and insulin pump use

  2009cited by this paper
• Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 2 diabetes: a meta-analysis.

  2009cited by this paper
• Continuous subcutaneous insulin infusion (CSII) 30 years later: still the best option for insulin therapy

  2009cited by this paper
• Breastfeeding and the basal insulin requirement in type 1 diabetic women.

  2009cited by this paper
• Medical Management of Pregnancy Complicated by Diabetes

  2009cited by this paper
• O81 Influence du niveau de conscience émotionnelle sur l’équilibre glycémique d’enfants et d’adolescents diabétiques de type 1

  2008cited by this paper
• Overnight CSII as supplement to oral antidiabetic drugs in Type 2 diabetes

  2008cited by this paper
• Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis

  2008cited by this paper
• Insulin and glucose profiles during continuous subcutaneous insulin infusion compared with injection of a long‐acting insulin in Type 2 diabetes1

  2008cited by this paper
• Continuous glucose monitoring and intensive treatment of type 1 diabetes.

  2008cited by this paper
• Basal—Prandial Insulin Delivery in Type 2 Diabetes Mellitus via the V-Go™: A Novel Continuous Subcutaneous Infusion Device

  2008cited by this paper
• Severe hypoglycaemia and glycaemic control in Type 1 diabetes: meta‐analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion

  2008cited by this paper
• A standardized protocol to achieve normoglycaemia during labour and delivery in women with type 1 diabetes.

  2008cited by this paper
• Improvement of cardiovascular risk factors in patients with type 2 diabetes after long‐term continuous subcutaneous insulin infusion

  2008cited by this paper
• Establishing glycaemic control with continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: experience of the PedPump Study in 17 countries

  2008cited by this paper
• Fetal growth in women managed with insulin pump therapy compared to conventional insulin.

  2008cited by this paper
• Macrosomia in well controlled CSII treated Type I diabetic pregnancy

  2008cited by this paper
• Use of Insulin Pump Therapy in the Pediatric Age-Group

  2007influential reference
• Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes.

  2007cited by this paper
• Long-term treatment combining continuous subcutaneous insulin infusion with oral hypoglycaemic agents is effective in type 2 diabetes.

  2007cited by this paper
• Continuous subcutaneous insulin infusion versus multiple daily injections of insulin: economic comparison in adult and adolescent type 1 diabetes mellitus in Australia.

  2007influential reference
• Clinical efficacy and patient satisfaction with U-500 insulin pump therapy in patients with type 2 diabetes.

  2007cited by this paper
• New technology, new errors: how to prime an upgrade of an insulin infusion pump.

  2007cited by this paper
• Effectiveness of Intensive Insulin Therapy by Multiple Daily Injections and Continuous Subcutaneous Infusion: A Comparison Study in Type 2 Diabetes with Conventional Insulin Regimen Failure

  2007cited by this paper
• Hypoglycemia and ketoacidosis with insulin pump therapy in children and adolescents

  2006cited by this paper
• Use of U-500 regular insulin by continuous subcutaneous insulin infusion in patients with type 2 diabetes and severe insulin resistance.

  2006cited by this paper
• A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes.

  2005cited by this paper
• Insulin pump therapy vs. multiple daily injections in obese Type 2 diabetic patients

  2005cited by this paper
• Pancreatic elastase-1 in stools, a marker of exocrine pancreas function, correlates with both residual beta-cell secretion and metabolic control in type 1 diabetic subjects: response to Cavalot et al.

  2005cited by this paper
• Should she or shouldn't she?: the relationship between infant feeding practices and type 1 diabetes in the genetically at risk.

  2005cited by this paper
• Insulin pumps. Not just for type 1.

  2005cited by this paper
• Glucose and insulin requirements during labor and delivery: the case for normoglycemia in pregnancies complicated by diabetes.

  2004cited by this paper
• Persistence of Benefits of Continuous Subcutaneous Insulin Infusion in Very Young Children With Type 1 Diabetes: A Follow-up Report

  2004cited by this paper
• A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine.

  2004cited by this paper
• Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of Type 1 diabetes in the UK.

  2004influential reference
• A caution regarding U-500 insulin by continuous subcutaneous infusion.

  2004cited by this paper
• A caution regarding U-500 insulin by continuous subcutaneous infusion.

  2004cited by this paper
• Parents' reflections on managing their children's diabetes with insulin pumps.

  2004cited by this paper
• Insulin pump therapy: a meta-analysis.

  2003cited by this paper
• A novel use of U-500 insulin for continuous subcutaneous insulin infusion in patients with insulin resistance: a case series.

  2003cited by this paper
• Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study.

  2003cited by this paper
• Insulin pumps

  2003cited by this paper
• Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes.

  2002cited by this paper
• Insulin pump therapy in pediatrics: a therapeutic alternative to safely lower HbA1c levels across all age groups

  2002cited by this paper
• Insulin pump therapy in the 21st century

  2002cited by this paper
• Use of insulin pumps in pregnancies complicated by type 2 diabetes and gestational diabetes in a multiethnic community.

  2001cited by this paper
• National Standards for Diabetes Self-Management Education

  2000cited by this paper
• The art and science of maintenance of normoglycemia in pregnancies complicated by insulin-dependent diabetes mellitus.

  1996cited by this paper
• Randomized Trial Comparing Continuous Subcutaneous Insulin Infusion and Conventional Insulin Therapy in Type II Diabetic Patients Poorly Controlled With Sulfonylureas

  1991cited by this paper
• Accelerated starvation in late pregnancy: a comparison between obese women with and without gestational diabetes mellitus.

  1990cited by this paper
• Food and Drug Administration Center for Devices and Radiological Health

  1988cited by this paper
• The relationship between large-for-gestational-age infants and glycemic control in women with gestational diabetes.

  1988cited by this paper
• Use of Intravenous Fluids Before Cesarean Section: Effects on Perinatal Glucose, Insulin, and Sodium Homeostasis

  1984cited by this paper
• Insulin and glucose requirements during the first stage of labor in insulin-dependent diabetic women.

  1983cited by this paper
• Constant Intravenous Insulin Infusion During Labor and Delivery in Diabetes Mellitus

  1982cited by this paper
• Effect of euglycemia on the outcome of pregnancy in insulin-dependent diabetic women as compared with normal control subjects.

  1981cited by this paper
• Feasibility of maintaining normal glucose profiles in insulin-dependent pregnant diabetic women.

  1980cited by this paper
• Reduction to normal of plasma glucose in juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump.

  1979cited by this paper
• Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia.

  1978cited by this paper
• Control of blood glucose in labour.

  1977cited by this paper
• Constant intravenous insulin infusion during labor and delivery in diabetes mellitus.

  1977cited by this paper
• Vaccination Against Poliomyelitis with Live Virus Vaccines—7

  1961cited by this paper

• Rethinking control-IQ+ technology: Simple strategies for easy optimization.

  2026cites this paper
• Insulin pump guide for health care professionals: settings, interpretation, and adjustment.

  2026cites this paper
• Accelerating care, capacity and equity in automated insulin delivery systems for New Zealanders with type 1 diabetes: the ACCESS-AID study protocol

  2026cites this paper
• Approach to the Hypoglycemic Patient.

  2026cites this paper
• Determining Insulin Pump Candidacy: The Disconnect Between Clinical Care Guidelines and Clinical Practice

  2025cites this paper
• Assessment of Carbohydrate-to-Insulin Ratio by Comparing Retrospective Carbohydrate Estimation Using Continuous Glucose Monitoring with Preprandial Carbohydrate Counting

  2025cites this paper
• Practical Approach to Continuous Glucose Monitoring Interpretation and Automated Insulin Delivery Use in Pregnancy: Considerations for Obstetric Providers

  2025cites this paper
• Advancing Telemedicine Using Smart Insulin Pens with Continuous Glucose Monitoring and Telecommunication Systems: A Case Series

  2025cites this paper
• Safety and Feasibility Evaluation of Automated User Profile Settings Initialization and Adaptation With Control-IQ Technology

  2024cites this paper
• Advancements in Insulin Pumps: A Comprehensive Exploration of Insulin Pump Systems, Technologies, and Future Directions

  2024cites this paper
• Insulin Requirements According to Sex and Weight in a Population of 9036 Adult Persons With Type 1 Diabetes Using Closed-Loop Insulin Delivery

  2024cites this paper
• Society for Ambulatory Anesthesia Updated Consensus Statement on Perioperative Blood Glucose Management in Adult Patients With Diabetes Mellitus Undergoing Ambulatory Surgery

  2024cites this paper
• Home Insulin Pump Use in Hospitalized Children With Type 1 Diabetes

  2024cites this paper
• Long-Term Benefits of an Integrated Continuous Glucose Monitoring and Insulin Pump System for Emergency Admissions, Hospitalization, and Metabolic Control in a Cohort of People With Diabetes: Retrospective Cohort Study

  2023cites this paper
• Therapy Settings Associated with Optimal Outcomes for t:slim X2 with Control-IQ Technology in Real-World Clinical Care

  2023cites this paper
• Expected Basal Insulin Requirement During Continuous Subcutaneous Insulin Infusion Therapy by Age Group, Sex, and Body Mass Index, Based on 25,718 Young People with Type 1 Diabetes in the DPV Registry

  2023cites this paper
• Advantages and disadvantages of connected insulin pens in diabetes management

  2023cites this paper
• Approach to the Hypoglycemic Patient.

  2023cites this paper
• Posicionamento Brasileiro sobre Síndrome da Quilomicronemia Familiar – 2023

  2023cites this paper
• Proof-of-concept Study of Using Supervised Machine Learning Algorithms to Predict Self-care and Glycemic Control in Type 1 Diabetes Patients on Insulin Pump Therapy.

  2023cites this paper
• The WHO-5 well-being questionnaire in type 1 diabetes: screening for depression in pediatric and young adult subjects

  2023cites this paper
• A Pharmacist-Led Practice to Improve Perioperative Glycemic Control in Elective Surgery.

  2023cites this paper
• Associations between insulin pump self‐management and HbA1c in type 1 diabetes

  2023influential citation
• Comparison of MiniMed 780G system performance in users aged younger and older than 15 years: Evidence from 12 870 real‐world users

  2022cites this paper
• Combination Use of U-500 Regular Insulin via Insulin Pump and Rapid-Acting U-100 Prandial Injections for Treatment of Pre-Existing Type 2 Diabetes in Pregnancy

  2022cites this paper
• Management of Individuals With Diabetes at High Risk for Hypoglycemia: An Endocrine Society Clinical Practice Guideline.

  2022cites this paper
• Insulin Pumps and Hybrid Close Loop Systems Within Hospital: A Scoping Review and Practical Guidance From the Joint British Diabetes Societies for Inpatient Care

  2022cites this paper
• Long-term Bene�ts in Emergency Admissions, Hospitalization and Metabolic Control of an Integrated Continuous Glucose Monitoring and Insulin Pump System in a Cohort of Diabetic Patients

  2022cites this paper
• Diabetes technology: A primer highlighting the role of the pharmacist

  2022cites this paper
• A mixed-method study examining family physicians’ perceptions regarding insulin pump therapy

  2022cites this paper
• Simulation-Based Evaluation of Dose Titration Algorithms for U-500R Insulin by Pump in Subjects with Type 2 Diabetes

  2021cites this paper
• Lost in Translation. A Disconnect Between the Science and Medicare Coverage Criteria for Continuous Subcutaneous Insulin Infusion (CSII).

  2021cites this paper
• Professional and flash on the monitoring of blood glucose levels of insulin pump therapy and without it

  2021cites this paper
• Real-World Patient Experience of Long-Term Hybrid Closed-Loop Insulin Pump Use.

  2021cites this paper
• Race/ethnicity and challenges for optimal insulin therapy.

  2021cites this paper
• The Effect of Prestudy Insulin Therapy on Safety and Efficacy of Human Regular U-500 Insulin by Pump or Injection: a post hoc analysis.

  2021cites this paper
• Self‐reported insulin pump prescribing practices in pediatric type 1 diabetes

  2021cites this paper
• Insulin Pump Treatment in Adults with Type 1 Diabetes in the Capital Region of Denmark: Design and Cohort Characteristics of the Steno Tech Survey

  2021cites this paper
• Barriers to Uptake of Insulin Technologies and Novel Solutions

  2021cites this paper
• Basal Insulin degludec and GLycemic control ComparEd to Aspart via insulin Pump in type 1 diabetes (BIGLEAP): a single-center, open-label, randomized, crossover trial.

  2021cites this paper
• Clinical Implementation of the Omnipod 5 Automated Insulin Delivery System: Key Considerations for Training and Onboarding People With Diabetes

  2021influential citation
• Simulation Platform Development for Diabetes and Technology Self-Management

  2021cites this paper
• Improved Glycemic Control Following Transition to Tubeless Insulin Pump Therapy in Adults With Type 1 Diabetes

  2021cites this paper
• How organizations shape medical technology allocation: Insulin pumps and pediatric patients with type 1 diabetes.

  2020cites this paper
• Impact of Medicare Continuous Subcutaneous Insulin Infusion Policies in Patients With Type 1 Diabetes

  2020influential citation
• Treatment Intensification With Insulin Pumps and Other Technologies in Patients With Type 2 Diabetes: Results of a Physician Survey in the United States

  2020cites this paper
• Factors associated with withdrawal from insulin pump therapy: A large‐population‐based study

  2020cites this paper
• Diabetes Technology in the Inpatient Setting for Management of Hyperglycemia.

  2020influential citation
• Update on Diabetes Medical Management: Epidemiology and Treatment

  2020cites this paper
• Inpatient Insulin Pump Management

  2020cites this paper
• The closed-loop artificial pancreas in 2020.

  2020cites this paper
• RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020

  2020cites this paper
• A discussion of healthcare support for adolescents and young adults with long-term conditions: Current policy and practice and future opportunities.

  2020cites this paper
• Building a Data-Driven Multiple Daily Insulin Therapy Model Using Smart Insulin Pens

  2020cites this paper
• A clinical review of the t:slim X2 insulin pump

  2020cites this paper
• Part II: Subcutaneous insulin infusion devices

  2020cites this paper
• Education programmes for persons with type 1 diabetes using an insulin pump: A systematic review

  2020cites this paper
• “Finding the Balance”: A Qualitative Study of the Experience of Nurses and Patients with Diabetes on an Insulin Pump in the Hospital

  2020cites this paper
• A guide for the pharmacist's role in insulin pump management during transitions of care

  2020cites this paper
• Effective Use of Insulin Pump in Patients with Type 1 Diabetes

  2020cites this paper
• Initial Basal and Bolus Rates and Basal Rate Variability During Pump Treatment in Children and Adolescents

  2020cites this paper
• Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression

  2020cites this paper
• Traitement par pompe à insuline : pour qui et comment le mettre en place en ambulatoire ?

  2020cites this paper
• Insulin Infusion Pumps, Automated Insulin Delivery and Artificial Pancreas Device Systems

  2020cites this paper
• RSSDI-ESI Clinical Practice Recommendations for the Management of Type 2 Diabetes Mellitus 2020

  2020cites this paper
• Service Evaluation

  2019cites this paper
• Insulin pump initiation and education for children and adolescents – a qualitative study of current practice in New Zealand

  2019cites this paper
• On the Horizon: Security Challenges at the Nexus of State and Non-State Actors and Emerging/Disruptive Technologies

  2019cites this paper
• The lived experience of continuous subcutaneous insulin infusion in adults with Type 1 Diabetes Mellitus: a phenomenological inquiry

  2019influential citation
• A Cross-Sectional Pilot Survey of Rural Clinic Attitudes and Proficiency with Insulin Pumps and Continuous Glucose Monitoring Devices

  2019cites this paper
• Advances in Type 1 Diabetes Technology Over the Last Decade

  2019cites this paper
• Insulin Pumps: Review of Technological Advancement in Diabetes Management.

  2019influential citation
• Insulin requirement profiles and related factors of insulin pump therapy in patients with type 2 diabetes

  2019cites this paper
• Insulin Pump Therapy

  2019cites this paper
• Insulin Pump Combined with Flash Glucose Monitoring: A Therapeutic Option to Improve Glycemic Control in Severely Nonadherent Patients with Type 1 Diabetes

  2019cites this paper
• Type 1 Diabetes Mellitus: a Century of approach

  2019cites this paper
• Home glucose meters: How accurate should they be to avoid dysglycemia in patients using carbohydrate counting?

  2019cites this paper
• Carbohydrate counting: How accurate should it be to achieve glycemic control in patients on intensive insulin regimens?

  2019cites this paper
• Role of Social Factors in Glycemic Control Among African American Children and Adolescents with Type 1 Diabetes.

  2019cites this paper
• An adaptive mealtime bolus calculator to minimize the effects of inaccurate carbohydrate counting

  2019cites this paper
• Insulin Infusion Pumps and Artificial Pancreas Device Systems

  2019cites this paper
• Accuracy of Bolus and Basal Rate Delivery of Different Insulin Pump Systems

  2019cites this paper
• AADE Practice Paper in Brief: Continuous Subcutaneous Insulin Infusion (CSII) Without and With Sensor Integration

  2018cites this paper
• An integrative review of the psychosocial facilitators and challenges of continuous subcutaneous insulin infusion therapy in type 1 diabetes

  2018cites this paper
• Type 1 Diabetes Mellitus

  2018cites this paper
• Ever-Increasing Insulin-Requiring Patients Globally

  2018cites this paper
• Principles of Care in the Diabetic Surgical Patient

  2018cites this paper
• Maternal and perinatal outcomes in pregnant women with type 1 diabetes treated with continuous subcutaneous insulin infusion and real time continuous glucose monitoring in two specialized centers in Medellin, Colombia

  2018cites this paper
• Moderne Therapie des Typ-1-Diabetes – Pumpentherapie mit Insulinanaloga

  2018cites this paper
• Approach to Using Trend Arrows in the FreeStyle Libre Flash Glucose Monitoring Systems in Adults

  2018cites this paper
• In/Visible Personal Medical Devices: The Insulin Pump as a Visual and Material Mediator Between Selves and Others

  2018cites this paper
• Experiences and decision making during paediatric transitions to continuous sub-cutaneous insulin infusion (CSII): A mixed method study

  2018cites this paper
• Impact of insulin pump use on disease control and quality of life in type I diabetes patients

  2018cites this paper
• Ambulatory Infusion Pumps: Coming to an Emergency Department Near You.

  2018cites this paper
• Continuous Subcutaneous Insulin Infusion Characteristics in Type 1 Diabetes Children and Adolescents in Qatar

  2018cites this paper
• Glycemic Management in Adults With Type 1 Diabetes.

  2018cites this paper
• Basic Insulin Pump Management

  2018cites this paper
• Ambulatory Pump Safety: Managing Home Infusion Patients Admitted to The Emergency Department and Hospital.

  2018cites this paper
• Continuous Glucose Monitoring and Insulin Informed Advisory System with Automated Titration and Dosing of Insulin Reduces Glucose Variability in Type 1 Diabetes Mellitus

  2018cites this paper
• Multiple Short Bouts of Walking Activity Attenuate Glucose Response in Obese Women.

  2018cites this paper